AdvisorShares Investments LLC Acquires New Shares in Henry Schein, Inc. (NASDAQ:HSIC)

AdvisorShares Investments LLC acquired a new position in shares of Henry Schein, Inc. (NASDAQ:HSIC) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 101,000 shares of the company’s stock, valued at approximately $6,989,000. Henry Schein makes up approximately 1.3% of AdvisorShares Investments LLC’s investment portfolio, making the stock its 24th biggest holding.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Versant Capital Management Inc raised its position in shares of Henry Schein by 274.6% during the fourth quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock worth $32,000 after acquiring an additional 335 shares during the last quarter. Venturi Wealth Management LLC boosted its holdings in Henry Schein by 3,347.1% in the fourth quarter. Venturi Wealth Management LLC now owns 586 shares of the company’s stock valued at $41,000 after acquiring an additional 569 shares during the last quarter. Quent Capital LLC increased its position in Henry Schein by 91.2% during the 4th quarter. Quent Capital LLC now owns 677 shares of the company’s stock valued at $47,000 after purchasing an additional 323 shares during the period. Smartleaf Asset Management LLC lifted its position in shares of Henry Schein by 23.2% in the 4th quarter. Smartleaf Asset Management LLC now owns 759 shares of the company’s stock worth $52,000 after purchasing an additional 143 shares during the period. Finally, City State Bank bought a new stake in shares of Henry Schein in the 4th quarter valued at $55,000. 96.62% of the stock is currently owned by institutional investors.

Insider Transactions at Henry Schein

In other Henry Schein news, CEO Bradford C. Connett sold 4,036 shares of the firm’s stock in a transaction dated Wednesday, March 19th. The shares were sold at an average price of $71.15, for a total value of $287,161.40. Following the completion of the sale, the chief executive officer now directly owns 62,688 shares in the company, valued at $4,460,251.20. This trade represents a 6.05 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. Also, Director Philip A. Laskawy sold 2,604 shares of the stock in a transaction on Wednesday, March 19th. The stock was sold at an average price of $71.04, for a total value of $184,988.16. Following the completion of the transaction, the director now owns 24,805 shares of the company’s stock, valued at approximately $1,762,147.20. This trade represents a 9.50 % decrease in their position. The disclosure for this sale can be found here. 1.14% of the stock is currently owned by company insiders.

Analyst Ratings Changes

A number of brokerages have commented on HSIC. StockNews.com cut shares of Henry Schein from a “buy” rating to a “hold” rating in a research report on Thursday, April 17th. Jefferies Financial Group increased their target price on shares of Henry Schein from $77.00 to $80.00 and gave the stock a “hold” rating in a research note on Thursday, January 23rd. Barrington Research reiterated an “outperform” rating and issued a $90.00 price target on shares of Henry Schein in a report on Wednesday, February 26th. UBS Group decreased their price target on shares of Henry Schein from $83.00 to $80.00 and set a “neutral” rating for the company in a research note on Wednesday, February 26th. Finally, Bank of America upgraded shares of Henry Schein from an “underperform” rating to a “buy” rating and lifted their price objective for the company from $69.00 to $84.00 in a report on Monday, January 6th. Six research analysts have rated the stock with a hold rating, five have given a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $81.10.

Henry Schein Stock Performance

Shares of NASDAQ HSIC opened at $65.57 on Tuesday. The stock has a market cap of $8.03 billion, a price-to-earnings ratio of 26.98, a P/E/G ratio of 2.13 and a beta of 0.84. The stock’s 50-day moving average is $68.97 and its 200 day moving average is $71.76. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46. Henry Schein, Inc. has a 1-year low of $60.56 and a 1-year high of $82.49.

Henry Schein (NASDAQ:HSIC) last released its quarterly earnings data on Tuesday, February 25th. The company reported $1.19 EPS for the quarter, missing the consensus estimate of $1.23 by ($0.04). Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The company had revenue of $3.19 billion during the quarter, compared to analysts’ expectations of $3.25 billion. During the same quarter in the prior year, the firm posted $0.66 EPS. The firm’s quarterly revenue was up 5.8% on a year-over-year basis. On average, sell-side analysts anticipate that Henry Schein, Inc. will post 4.74 EPS for the current fiscal year.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.